Special Issue of Pharmaceuticals journal

Are you modifying phages, genetically or chemically, to improve their ability to act as therapeutics? Attaching toxins so the phage capsid provides specificity to target bacteria? Creating phage based vaccines? If you are making modified phages for treatments, please consider contributing to a special issue of Pharmaceuticals titled "Bacteriophages as Therapeutic Delivery Vehicles" edited by Paul Hyman (phyman@ashland.edu), Tina Schneider (clschnei@carrollu.edu), and Bryan Gibb (bgibb@nyit.edu). Contact us for more information.